Methylenetetrahydrofolate-dehydrogenase 1958G→A polymorphism is a genetic determinant of NTD risk for Italian mothers by unknown
BioMed Central
Page 1 of 1




polymorphism is a genetic determinant of NTD risk for Italian 
mothers
P De Marco, M Grazia Calevo, E Merello, A Moroni, A Raso, S Parodi, A Cama 
and V Capra*
Address: Laboratorio U.O. di Neurochirurgia, Istituto G. Gaslini, Genova, Italia
Email: V Capra* - valeriacapra@ospedale-gaslini.ge.it
* Corresponding author    
Neural Tube Defects (NTDs) have a well-established
genetic basis, although specific genetic predisposing fac-
tors had not been identified until now. Genetic variants of
enzymes involved with folate pathway might be expected
to have impact on NTD risk. Given its key role in folate
metabolism, the methylenetetra-hydrofolate dehydroge-
nase (MTHFD1) could represent an attractive candidate in
NTD etiology. MTHFD1 is a trifunctional protein and
mediates the interconversion of 5,10-MTHF; 5,10-methe-
nylTHF; and 10-formylTHF. 10-formyl THF and 5,10-
methenylTHF are the donor cofactors for de novo purine
and pyrimidine biosynthesis and, thus, the biosynthesis
of DNA. Recently, a polymorphism, G1958A, in the
MTHFD1 gene was suggested as maternal genetic risk fac-
tor for NTD in the Irish population. In this study, we
examined the impact of the MTHFD1 G1958A polymor-
phism on NTD risk in the Italian population by a case-
control study and family-based studies. The study popula-
tion consisted of 95 unrelated Italian NTD children, 42
mothers and 40 fathers who were recruited from the Spina
Bifida Center of the Gaslini Hospital, Genoa. A total of
145 healthy individuals were recruited from a blood
donors accessible bank and used as control group. The
presence of the MTHFD1 1958G→A, MTHFR (methylene-
tetrahydrofolate reductase) 1298A→C and RFC-1
(reduced folate carrier 1) 80A→G polymorphisms was
investigated by PCR-RFLP methods. We found no
increased risk for MTHFD1 mutant genotypes of the chil-
dren and fathers. On the contrary, significant risk esti-
mates resulted for the homozygous 1958AA genotype of
the mothers (OR = 3.05; P = 0.046). This maternal effect
was confirmed by transmission disequilibrium test (TDT)
that showed no preferential transmission of 1958A allele
to the affected children from informative parents. Since
our previous study has shown that the MTHFR A1298C
and RFC-1 A80G polymorphisms are genetic determinant
of NTD risk for Italian mothers, potential gene-gene inter-
actions were examined. We found a significant interaction
between the MTHFD1 G1958A polimorphism and both
MTHFR A1298C (4.46-fold increased risk) and RFC-1
A80G (9.14-fold increased risk) mutant alleles in the
mothers. We conclude that a common genetic variant of
MTHFD1 gene, the G1958A, is a maternal genetic risk fac-
tor for NTD. These findings highlight the importance of
further considering maternal genotype when evaluating
NTD susceptibility loci.
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